Abstract
ALTHOUGH a number of drugs are available for the treatment of liver fluke disease in sheep and cattle, they are all liable to produce unpredictable toxic effects, with occasional deaths, when used under farm conditions. This is particularly true in cattle, and the precautionary measures often required during their use are such that valuable animals may not be treated routinely for the condition. These untreated animals act as important reservoir hosts for the parasite and thus help perpetuate the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BROOME, A., JONES, W. A New Drug for the Treatment of Fascioliasis in Sheep and Cattle. Nature 210, 744–745 (1966). https://doi.org/10.1038/210744a0
Issue Date:
DOI: https://doi.org/10.1038/210744a0
This article is cited by
-
The chemotherapeutic activity of selected fasciolicides against immatureFasciola hepatica in mice
Experientia (1973)
-
Oxyclozanide—Activity against fasciola gigantica in naturally infected buffalo, cattle, sheep and goats
Tropical Animal Health and Production (1971)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
